Focus on cardiovascular diseases in Mena region
Riyadh, March 17, 2014
The current scenario of cardiovascular diseases prevalent in the Mena region were discussed at a convention in Colombo recently.
The second version of Tabuk Cardiovascular Convention (2nd TCC), which was organised by Saudi Arabia-based Tabuk Pharmaceuticals, also discussed the challenges being faced by modern cardiologists and the latest advancement in the field of cardiology.
A number of prominent speakers talked about key cardiovascular issues such as "Cardiovascular disease in the developing world: prevalence, patterns, and The potential for early disease detection"; "Focus on HDL elevation or further LDL lowering?"; "Diabetes Mellitus & Cardiovascular Disease"; and "2013 ACC/AHA Guidelines on reducing LDL-C and atherosclerotic cardiovascular risk in adults."
It was aimed at raising awareness on the dangers and implications of cardiovascular condition in the Mena region, while fostering collaboration among KOLs to help curb cardiovascular diseases’ burden in the region by sharing the latest knowledge and insights.
Dr Haitham Baghdadi, MD, corporate medical affairs manager, Tabuk, said: "In the Mena region, 45 per cent of total deaths are caused by coronary artery disease where dyslipidemia is the single largest cardiovascular disease risk factor and high blood pressure is the second leading cause of death and disability in this region.
“Therefore, TCC experts highlighted these serious problems and recommended effective methods of improving cardiovascular patients care which can help them in maintaining healthier hearts and having better lives.'' - TradeArabia News Service